ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 629713 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 629713; 2) Community: the network communities that were significantly associated with the response to NSC 629713; 3) Molecule: the relationships between components within communities and NSC 629713; 4) MDR: the compounds that were significantly associated with the NSC 629713.

NSC Compound Enrichment Correlation
NSC 276382 PEPLEOMYCIN 0.0446159312763235 0.039952507
NSC 348121 4,6-Methano-5H-benz[h]oxazolo[3,2-a]pyrazino-[3,2,1-de][1,5]naphthyridine-7-carbonitrile, 1,2,3a,4,4a,6,7,9,10,13,13b,13c-dodecahydro-9-(hydroxymethyl)-11-methoxy-5,12-dimethyl-10,13-dioxo- 0.0446159312763235 0.22768088
NSC 711104 Null 0.0446159312763235 -0.017392487
NSC 734977 Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate 0.0446159312763235 -0.072181363
NSC 116789 Acovenoside B 0.0459335986102865 0.015347391
NSC 132483 Aminopterin Derivative 0.0459335986102865 -0.079841006
NSC 284751 Adenosine, 8-chloro-, cyclic 3',5'-(hydrogen phosphate) 0.0459335986102865 -0.33012162
NSC 606985 Camptothecin Derivative 0.0459335986102865 -0.022936736
NSC 609397 B817373K328 0.0459335986102865 0.19367592
NSC 644043 Null 0.0459335986102865 -0.073047915
Total:50  Current:41    [First] [Prev] [Next] [Last]